Buy SCYNEXIS Stock | SCYX Stock Price & Latest News | Public.com
SCYX

SCYNEXIS

$0.00 (0.00%)Today
    Small Market Cap
    View SCYNEXIS (SCYX) stock trends here

    About SCYX

    SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, an...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.09
    -1.25
    -2.58
    -3.92
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.76

    Actual EPS
    Q2 2021

    Stats

    Market Cap$159,41M
    Volume127,2k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$10.40
    1 Year Low$4.20
    Open$7.45
    High$7.70
    Low$7.22

    Buy any stock with any amount of money.

    Download the App
    Download the app